Common side effects of Gilenya include: infection, back pain, diarrhea, increased serum alanine aminotransferase, increased serum aspartate aminotransferase, and increased liver enzymes.
Other side effects include: blurred vision, bradycardia, bronchitis, increased gamma-glutamyl transferase, lymphocytopenia, migraine, dizziness, dyspnea, hypertension, increased serum transaminases, and tinea.
See below for a comprehensive list of adverse effects.
The most common adverse events were headache, influenza, diarrhea, back pain, liver transaminase elevations, and cough.
Common (1% to 10%): Hypertension, first degree AV block, bradycardia Uncommon (0.
1% to 1%): Symptomatic bradycardia, second degree AV blockRare (0.
01% to 0.
1%): Peripheral arterial occlusive diseaseVery rare (less than 0.
01%): Hemophagocytic syndrome Frequency not reported: Heart rate decrease, Mobitz type I (Wenckebach) block, Mobitz type II blockPostmarketing reports: Third degree AV block, AV block with junctional escape, transient asystole, peripheral arterial occlusive disease
In the majority of cases, elevations in liver enzymes occurred within 6 to 9 months and returned to normal within approximately 2 months following discontinuation of fingolimod (the active ingredient contained in Gilenya) 
Very common (10% or more): ALT/AST increased (14%)Common (1% to 10%): Elevation in liver transaminases, GGT increased, hepatic enzyme increased, liver function test abnormal
Infections occurred at a rate similar to placebo.
Very common (10% or more): Influenza viral infection (13%), sinusitis (10.
9%), infectionsCommon (1% to 10%): Herpes viral infection, bronchitis, gastroenteritis, tinea infection Uncommon (0.
1% to 1%): PneumoniaFrequency not reported: Fatal herpetic infection, fatal varicella zoster virus infection
Symptoms of posterior reversible encephalopathy syndrome included sudden onset of severe headache, altered mental status, visual disturbances, and seizure.
Very common (10% or more): Headache (25%)Common (1% to 10%): Dizziness, paresthesia, migraine Rare (less than 0.
1%): Posterior reversible encephalopathy syndrome, ischemic and hemorrhagic stroke Frequency not reported: Neurological atypical disordersPostmarketing reports: Syncope
Very common (10% or more): Diarrhea (12%)
Common (1% to 10%): Lymphopenia, leukopeniaUncommon (0.
1% to 1%): Neutrophil count decreased
Macular edema occurred at a dramatically higher rate in patients with a history of uveitis.
Common (1% to 10%): Vision blurred, eye painUncommon (0.
1% to 1%): Macular edema
Very common (10% or more): Cough (10%)Common (1% to 10%): Dyspnea, reduction in diffusion lung capacity, reduction in FEV1
Very common (10% or more): Back pain (12%)
Common (1% to 10%): Alopecia, eczema, pruritus
Common (1% to 10%): Weight decreased, blood triglycerides increased
Common (1% to 10%): Asthenia Postmarketing reports: Unexplained death
Common (1% to 10%): DepressionUncommon (0.
1% to 1%): Depressed mood
Frequency not reported: Lymphoma
Postmarketing reports: Rash, urticaria, angioedema
Blurred vision
chills
cough
cough-producing mucus
diarrhea
difficult or labored breathing
dizziness
fever
general feeling of discomfort or illness
headache
joint pain
loss of appetite
muscle aches and pains
nausea
nervousness
pounding in the ears
runny nose
shivering
slow or fast heartbeat
sore throat
sweating
tightness in the chest
trouble sleeping
unusual tiredness or weakness
vomiting
Black, tarry stools
burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings
chest pain or discomfort
cough or hoarseness
headache, severe and throbbing
lightheadedness, dizziness, or fainting
lower back or side pain
painful or difficult urination
sores, ulcers, or white spots on the lips or in the mouth
swollen glands
unusual bleeding or bruising
Weight loss
yellow skin and eyes
Back pain
pain or tenderness around the eyes and cheekbones
stuffy nose
Abdominal or stomach pain
decreased weight
depression
eye pain
hair loss or thinning of the hair
itching in the genital or other skin areas
itching skin
lack or loss of strength
scaling
skin rash, encrusted, scaly, and oozing
weakness